Moms Helping Moms
- Pediatric Clinical Trials are on the Rise as New
Law Goes Into Effect
August 9, 2000 MedscapeWire
"When parents give children a medication, they're often engaging in a
mini clinical trial of their own," says Mark S. Schreiner, MD, medical director of
the Children's Clinical Research Institute at The Children's Hospital of
Philadelphia. "That will change in December...when a new law goes into effect requiring that
all new drugs and new formulations of existing drugs be tested for use in children."
Dr. Schreiner explains that there is a tremendous amount of variability from person
to person in the way drugs are absorbed and metabolized in the body.
There are also genetic differences among people that affect how certain drugs do
or don't work in diverse populations. "Anytime a patient gets a drug, it's an
experiment to see if it works for that particular patient. But with children, we're
even more in the dark because we don't have the same quality information as we do for
adults. Currently, only about 20% of the drugs on the market are well studied in children."
The US Food and Drug Administration (FDA) has been concerned about this issue for more than 20 years. On a national level, some 180 pediatric drug trials are
typically conducted every year. Based on the number of drugs approved
in the last 5 years with potential benefit for children, the FDA approximates that
an additional 375 pediatric trials should be conducted on an annual basis.
This dramatic increase in the number of pediatric clinical trials raises a number of
issues for parents. Many more parents will be approached by physicians, asking for
permission to enroll their children in drug trials. Parents will have a number of
questions: "Is it safe to give my child a drug for which there is inadequate
information? Or is it safer to enroll my child in a clinical trial?"
"When we conduct clinical trials, the safety of the child is our utmost concern,"
states Dr. Schreiner. "All aspects of a clinical trial are preapproved
by the FDA and by an institutional review board. That means all of us are performing
the same procedures in the same way. And from an educational point of view, everyone involved in conducting the trial shares information and experiences,
and contributes to problem solving. The level of surveillance in terms of number of
visits and attention to the individual child is usually much higher than during routine medical care.... A well-written clinical trial reflects the best care."
Dr. Schreiner points out another important safety factor. "We usually
do not test drugs in children unless the drugs have first been tested in adults.
So we do know more about the drug and its likely benefits before we start. An
exception would be when the drug affects only children. For example, a clinical trial for
a new vaccine may be tested in babies."
Children's studies also broach ethical questions. Parents must make decisions as
trustees for their children because children are not legally or developmentally able to
make those decisions on their own. "Pediatricians should become involved in this
decision-making process," urges Dr. Schreiner. "They should scientifically review
the study and in their own minds come to a decision about its value for their patients."
"From my perspective, there is never a justification for any individual patient to take
on undue risk to benefit the rest of society. On the other hand, if children do not
participate in trials, then children as a group will not benefit," he says.
"One of the principles behind all research is the idea of distributive justice. That is,
there must be a balance between the burdens of research and the benefits of
research. We have inadequate information regarding the safety and effectiveness of
drugs for children. As a result, children have not been equal recipients of the great
advances in medicine and drug research. If we want to see children partake of the
benefits, then we, as parents and society, must accept a communal obligation to bear some of the burden.
"We were all children, many of us will have children, and our children will have
children. So we all have a stake in this. It's ironic that by protecting children from
risks, we have also denied them the benefits," Dr. Schreiner concludes.
Dr. Schreiner advises pediatric clinical researchers to ensure that parents have the
answers to the following questions before signing a consent form.
How and why would we be approached to have our child participate
in a clinical trial? A child's pediatrician may ask for a child's participation based
on the pediatrician's knowledge of the child's medical history. If a child is
hospitalized or is being seen in a clinic, parents may be approached directly
by an investigator or a clinical coordinator. Some hospitals maintain a
database of patients and diagnoses. The database may be searched
if researchers are looking for children with a particular disease or
condition. In a hospital setting, physicians meet at least once a week to
review challenging cases. It's very important that parents do not feel pressured
into making a decision, especially if the person making the request is the
Does my child have the disease or problem that the study targets?
A drug study should always be a match for the child. Obviously, a
child should not participate in the study of an epilepsy drug unless
the child has epilepsy. However, some conditions are so common that all
children will benefit by having any child participate. For example, researchers
may be investigating a new drug to treat fever or ear infections in
Will my child be able to cope with a trial?
Parents know their children better than anyone else. Listen to
parents when they express doubts that their child may not have the temperament
or personality to cope with the disciplined regimen required by a clinical trial.
However, it is important to remind parents that children have a great sense of
altruism and they will benefit by understanding that they're helping others.
What is a protocol?
A protocol is the document by which all research studies flow. It's essentially
the research "bible" that outlines the exact procedures for the investigator to
follow. There must be no deviation. A protocol begins by explaining what is
being studied and why. It will also include the name of the sponsor and the
names of the principal investigators. The sponsor may be a pharmaceutical
company, the National Institutes of Health, or a foundation. The protocol will
describe the study design, how many people will be in the study, how many
times each patient will be seen, what laboratory tests will be done and how
often. It will also explain the risks and potential benefits of the study. The
protocol also contains all the information required by the FDA.
What is involved in the study?
Parents should receive a verbal explanation of the study and the
details of the protocol should be included in a written consent form. Although
the consent form should provide most of the details, there are a few extra
items parents may want to ask about. For example, will a parent be actively
involved with collecting and reporting data? If the child is older, will he or
she be required to keep a diary or to phone in reports? How many visits will
there be? Will blood be drawn? What are the risks? The expected benefits?
What are the doctor's hours?
Does the investigator have evening and weekend hours? Parents will want to
minimize disruptions to their work schedule and to their child's school day.
When parents arrive at your office, or the office of the clinical investigator,
they'll want to know that they will you be seen promptly. Parents should be
reassured that when participating in a trial, they should be seen right away
without waiting as they might for a routine office visit.
Will my child be safe?
The FDA has established strict guidelines for how clinical trials are to be
conducted. It requires the sponsor of the trial to scrutinize the credentials of
the clinical investigators who conduct the trial. The children being studied in
the trial will be monitored closely during the trial and may need to be seen
Will we be compensated for participating?
If there are no extra visits or procedures, parents should not expect to
receive any compensation. However, if there are, parents should expect to
be compensated for the trouble they take to participate in a study. This
includes reimbursement for transportation, meals, and overnight accommodations. The child may also be offered a small gift, such
as a savings bond or a gift certificate for toys or books. However, parents should
be wary of expensive gifts as a lure to participate in a study.
What if my child is a girl of childbearing age?
Because there is so little information about the effects of drugs on pregnant
women and developing fetuses, drug companies and clinical investigators will
want to be sure that a young woman who might participate is not pregnant
and will not become pregnant during the course of the trial. This may be a
difficult issue for parents of young girls who are capable of child-bearing but
are not yet sexually active. A pharmaceutical company may require her to
take a pregnancy test and may also require her to use some form of birth
control. Some companies may accept abstinence as a means of birth control.
Is the doctor experienced? Has he or she conducted studies previously?
Emphasize to parents that they have a right to ask for the credentials of the
principal investigator and of anyone else involved in the trial.
Is there an experienced study coordinator, nurse, or other resource person
who is going to be available to me? Parents should ask to meet the principal investigator, the study
coordinator,and anyone else who will work with them during the study. It's important for them to feel at ease with everyone involved and to be confident
they will be available whenever there are questions or problems.
Has the protocol been reviewed by an Institutional Review Board (IRB)?
The Institutional Review Board is a committee within the organization or
hospital that ensures the protection and ethical treatment of all participants in
a clinical study. The IRB is an impartial, independent group that has no
relationship with the individual clinical trial.
If my child is injured during the course of the trial, who is responsible for
paying for the cost of his or her treatment? Usually this issue is addressed in the consent form. Parents
should discuss this topic with the investigator before signing the form.
Can we drop out of the trial at any time?
Parents should understand that they can drop out of the trial at any time, for
any reason, and without a penalty. Do I understand the consent form?
Parents will be given a detailed consent form to sign. Remind them that the
form should be written in a language they speak with words that they can
understand. Informed consent is not a single event. It is an ongoing process
during which parents must have time to understand, to make an informed
decision, and to continually reevaluate their willingness to participate. Parents
should be given a copy of the consent form so that they can reread it for
more information about the study details.
What if I have trouble making a decision?
In some instances, parents are overwhelmed, especially if they have just
learned that their child has a serious illness. Be relaxed and considerate with
parents; ask them to sit back and listen to what the clinical investigator has to
say. They should try to take in as much information as they can and read
through the materials presented. Remind parents that they can consult with
the child's pediatrician and other healthcare professionals.
Parents should know that it is all right to decline if the study is not a good
match for them or their child.
Medscape Wire is prepared by Deborah Flapan, associate editor at
Medscape. Send press releases and comments to email@example.com.
Publisher of Healthy Child Newsletter
Vital, In-depth Information on Children's Health Issues
- For Simple Ways to
Fundraise using Safe, Non Toxic Products people use everyday